Almirall, S.A
Almirall, S.A., a pharmaceutical company, engages in the research, development, manufacture, and sale of medicines worldwide. The company offers its products for dermatological diseases comprising actinic keratosis, atopic dermatitis, acne, rosacea, and psoriasis; and central nervous system, cardiovascular, and gastrointestinal diseases. Its strategic brands include ACTIKERALL, BALNEUM, DECODERM, SATIVEX, SKILARENCE, and DECODERM. Almirall, S.A. has a strategic research collaboration with Evotec AG to discover and develop first-in-class therapeutics in the field of dermatology diseases, as well as drug discovery partnership with X-Chem, Inc.; and a research collaboration with Iktos in the area of artificial intelligence for new drug design. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain. Show More...
-
Website http://www.almirall.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 8.57 EUR
-
Last Updated 26-04-2024
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 0.71 0.51 0.44 -0.2 2.59 0.76 0.44 -1.76 0.41 0.6 0.71 Dividends EUR 0.33 0.29 0.17 0.15 0.2 0.19 0.19 0.18 0.2 0.2 Payout Ratio % * 42.0 56.0 38.2 382.5 7.2 20.2 42.6 28.6 Shares Mil 166.0 166.0 173.0 173.0 173.0 173.0 173.0 173.0 188.0 188.0 174.0 Book Value Per Share * EUR 4.93 5.17 5.42 5.46 5.44 8.09 8.84 7.71 6.92 7.34 7.7 Free Cash Flow Per Share * EUR 1.44 0.91 0.2 -0.23 -0.11 4.28 0.87 -0.93 0.61 -2.35 Return on Assets % 7.86 5.62 5.42 -2.16 20.79 5.2 2.82 -12.17 3.4 4.39 5.14 Financial Leverage (Average) 1.88 1.7 1.47 2.0 1.9 1.73 1.85 1.92 2.0 1.91 1.77 Return on Equity % 15.11 10.06 8.58 -3.72 40.26 9.41 5.06 -22.91 6.68 8.57 9.69 Return on Invested Capital % 11.97 7.45 7.59 -3.18 31.21 7.49 4.09 -18.72 4.96 7.12 7.73 Interest Coverage 14.1 5.89 -438.85 9.66 9.42 Current Ratio 2.48 1.1 1.24 0.84 3.07 3.8 1.99 1.48 1.7 1.51 1.64 Quick Ratio 1.96 0.81 0.6 0.47 2.66 3.27 1.59 1.01 1.14 1.01 0.96 Debt/Equity 0.36 0.02 0.3 0.25 0.23 0.22 0.23 0.45 0.22 0.36